| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 圳普门科技股份有限公司是一家研发和市场双轮驱动的专业化高科技医疗设备企业，国家高新技术企业，科创板上市企业，（股票简称：普门科技；股票代码：688389）。致力于体外诊断、治疗康复、皮肤医美和消费者健康产品的研发、制造、全球销售和服务。 公司荣获国家科学技术进步奖一等奖、荣获中国分析测试协会科学技术奖【特等奖】、荣获深圳市科学技术进步奖一等奖等。经过国家六部委批准设立【院士工作站】；建成了“广东省工程技术研究中心”、“深圳市工程技术研究中心”、“深圳市工程实验室”、“深圳市企业技术中心”、“博士后创新实践基地”等6大技术创新平台。先后承担国家科技部、发改委、工信部、省级、市区级研发及产业化项目30多项。 在体外诊断领域，建成中国第一家、全世界第二家电化学发光免疫分析平台，以及免疫比浊、液相色谱等检测技术平台，自主开发专业化、特色化的体外诊断设备和配套试剂。 在治疗康复领域，提供包括呼吸、围术与重症治疗，VTE防治能力建设，创面治疗与修复，疼痛治疗与康复，内窥镜诊疗等解决方案。 先后收购重庆京渝激光技术有限公司和深圳为人光大科技有限公司，进一步丰富和完善了公司在医疗美容产品领域的布局。 公司具有包括研究开发、生产制造、销售服务和质量管理等体系完善的医疗器械产业化平台，在全国积极打造体外诊断、治疗康复、皮肤医美和消费者健康产品产业链。 目前，普门科技研发的诊疗产品在全国20000多家医院装机使用，取得了显著的临床诊疗效果，临床医生和患者给予了极高的评价，社会效益非常显著。装机医院包括2000余家知名三级医院。产品远销全球100多个国家和地区，覆盖欧洲、亚洲、南美洲、中东及非洲等市场。 | ||||||||||||||||||||||||
| Main Business | 医疗器械的研发、制造、全球营销及服务，专注于体外诊断（体外诊断设备及配套检测试剂）、临床医疗、皮肤医美、消费者健康产品的开发及技术创新。 | ||||||||||||||||||||||||
| Legal Representative | 刘先成 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 路曼 | ||||||||||||||||||||||||
| Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0755-29060052 | ||||||||||||||||||||||||
| Fax No | 0755-29060036 | ||||||||||||||||||||||||
| Website | www.lifotronic.com | ||||||||||||||||||||||||
| bod@lifotronic.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 05/11/2019 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.770 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.281 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.197 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 6.444B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |